>>I am part of a consortium that is putting together a bid to the
>EEC's 6th Framework Programme. We are interested in platform
>technologies for vaccine delivery and would like to conatct partners
>who would be interested in providing suitable antigens for
>incorporation into our delivery systems. Ideally we need antigens
>with proven efficacy, criteria to measure whether the delivery
>system improved therapeutic outcome e.g. cytokine/specific antibody
>production, and a method to allow large quantities of the antigen
>tobe produced under GMP conditions. I would be happy to hear from
>anyone willing to collaborate on this application.
>>Chris Carter
--
Dr. Chris Carter,
Department of Immunology,
SIBS,
University of Strathclyde,
Glasgow,
G4 ONR
Phone: 0141-548-3823/3748 (direct)
0141-552-4400 ext 3823 (switchboard)
0141-548-3748 (secretary)
Fax: 0141-548-3427
